Open AccessThe Intersection of Age and Tumor Biology with Postoperative Outcomes in Patients After Cytoreductive Surgery and HIPEC
Author(s) -
Michael K. Turgeon,
Adriana C. Gamboa,
Rachel Lee,
Mohammad Y. Zaidi,
Charles W. Kimbrough,
Travis E. Grotz,
Keith F. Fournier,
Benjamin D. Powers,
Seán Dineen,
Jula Veerapong,
Callisia N. Clarke,
Harveshp Mogal,
Sameer H. Patel,
Laura Lambert,
Sean M. RonnekleivKelly,
Mustafa Raoof,
Nadege Fackche,
Jonathan B. Greer,
Charles A. Staley,
Jordan M. Cloyd,
Shishir K. Maithel,
Joshua H. Winer
Publication year - 2020
Publication title -
annals of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.764
H-Index - 173
eISSN - 1534-4681
pISSN - 1068-9265
DOI - 10.1245/s10434-020-08538-y
Subject(s) - medicine , surgical oncology , hyperthermic intraperitoneal chemotherapy , conventional pci , histology , adenocarcinoma , abdominal surgery , retrospective cohort study , surgery , cytoreductive surgery , cancer , myocardial infarction , ovarian cancer
Patient age is a significant factor in preoperative selection for major abdominal surgery. The association of age, tumor biology, and postoperative outcomes in patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) remains ill-defined.